title: Ecstasy induced acute hepatic failure. Case reports.
abstract: 3,4-methylenedioxymethamphetamine (MDMA), an amphetamine derivative known as ecstasy, has stimulating and hallucinogenic properties. It has become a substance that is widely used especially by young people. Hepatotoxicity is one of the rare side effects of this substance and can be fatal. Ecstasy-induced fulminant hepatitis has been reported in case reports. The clinical course and the prognosis of the cases may differ. In this article, two cases in whom ecstasy-induced fulminant hepatic failure had developed and who were treated with liver transplantation, and one case which recovered with treatment, have been presented.
authors.forename: Y
authors.initials: Y
authors.lastname: Atayan
authors.forename: Y F
authors.initials: YF
authors.lastname: Çağın
authors.forename: M A
authors.initials: MA
authors.lastname: Erdoğan
authors.forename: M M M
authors.initials: MM
authors.lastname: Harputluoglu
authors.forename: Y
authors.initials: Y
authors.lastname: Bilgic
mesh_terms: D000293:Adolescent; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000209:etiology* / Q000473:pathology; D017809:Fatal Outcome; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D019934:International Normalized Ratio; D008099:Liver / Q000473:pathology; D017114:Liver Failure, Acute / Q000097:blood / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D012709:Serum Albumin; D055815:Young Adult
chemical_list: D006213:Hallucinogens; D012709:Serum Albumin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D001663:Bilirubin